Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Northvale, New Jersey
- Most recent report
- 8-K, filed Aug 13, 2026
- Incorporated
- New Jersey
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1053369
- Fiscal year ends
- March
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 101
News 8 of 270
- 8-K Quarterly results Aug 13, 2026
- 8-K/A Current report on a material event, amended Aug 11, 2026
- 8-K Current report on a material event Aug 10, 2026
- 8-K Current report on a material event Aug 4, 2026
- 8-K Quarterly results Jun 29, 2026
- 8-K Current report on a material event Jun 23, 2026
- 8-K Current report on a material event Jun 15, 2026
- 8-K Current report on a material event Jun 1, 2026
Prospectuses and Registrations 8 of 48
- S-8 Registration statement for an employee plan Jul 1, 2024
- S-8 Registration statement for an employee plan Mar 28, 2024
- S-8 Registration statement for an employee plan Mar 28, 2024
- 424B3 Prospectus supplement for an offering Jul 27, 2020
- S-3 Shelf registration statement Jul 15, 2020
- 424B3 Prospectus supplement for an offering Jun 5, 2017
- S-3/A Shelf registration statement, amended Jun 2, 2017
- S-3 Shelf registration statement May 10, 2017
Proxies 8 of 23
- DEFA14A Extra proxy material May 11, 2020
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2020
- PRE 14A Preliminary proxy statement Apr 17, 2020
- DEFA14A Extra proxy material Oct 18, 2019
- DEF 14A Proxy statement for a shareholder vote Oct 10, 2019
- PRE 14A Preliminary proxy statement Sep 27, 2019
- DEFA14A Extra proxy material May 5, 2014
- DEF 14A Proxy statement for a shareholder vote Apr 3, 2014
Ownership 8 of 461
- 4 Insider reported a trade Jan 13, 2026
- 4 Insider reported a trade Oct 3, 2025
- 4 Insider reported a trade Aug 26, 2025
- 144 Notice of a proposed sale of restricted stock Aug 22, 2025
- 4 Insider reported a trade Jul 25, 2025
- 4 Insider reported a trade Jul 10, 2025
- 4 Insider reported a trade Jul 8, 2025
- 144 Notice of a proposed sale of restricted stock Jul 8, 2025
Other 8 of 97
- UPLOAD Comment letter from SEC staff Apr 14, 2026
- CORRESP Reply to SEC staff Mar 18, 2026
- UPLOAD Comment letter from SEC staff Mar 4, 2026
- UPLOAD Comment letter from SEC staff Feb 28, 2024
- CORRESP Reply to SEC staff Feb 20, 2024
- UPLOAD Comment letter from SEC staff Jan 22, 2024
- UPLOAD Comment letter from SEC staff Mar 12, 2021
- CORRESP Reply to SEC staff Feb 22, 2021
Everything here comes from Elite Pharmaceuticals Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.